PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
10-Feb-2021 Sygnature Discovery & Altasciences Join Forces For New Webinar Series Sygnature Discovery
10-Feb-2021 PTC technology accelerates Watson-Marlow’s digital transformation plans PTC
10-Feb-2021 Biogen’s main MS assets facing increasing competition and further losses in the MS market, says GlobalData Biogen
10-Feb-2021 Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan B3C newswire
10-Feb-2021 Oxular Limited Appoints Dr. Jatinder Kapur as Vice President of Quality Oxular
10-Feb-2021 XPhyto Therapeutics Corp.: XPhyto Adds Mescaline Production to Psychedelic Medicine Programs XPhyto Therapeutics Corp.
10-Feb-2021 European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar Ataxia B3C newswire
10-Feb-2021 Relief Confirms Release of Preliminary Findings from Phase 2b/3 Trial of Intravenous RLF-100(TM) (aviptadil) RELIEF THERAPEUTICS Holdings AG
09-Feb-2021 OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectus OncoZenge
09-Feb-2021 Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™ Freeline Therapeutics Holdings plc
09-Feb-2021 Nanoform and Herantis sign Biologics Proof of Concept Agreement Nanoform
09-Feb-2021 Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline Anticancer Bioscience
09-Feb-2021 SMC Issues Positive Decision for Treatment with AbbVie’s RINVOQ®▼(upadacitinib) in Severe Active Rheumatoid Arthritis (RA) Scottish Medicines Consortium
09-Feb-2021 SCOTTISH APPROVAL OF A NEW TREATMENT FOR PEOPLE WITH CHRONIC PULMONARY RESPIRATORY DISEASE (COPD) - FORMOTEROL FUMARATE DIHYDRATE/GLYCOPYRRONIUM BROMIDE/BUDESONIDE[i] AstraZeneca
09-Feb-2021 Janssen Announces Treatment with ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer Janssen
09-Feb-2021 Ipsen and Mendelian Announce Landmark Partnership to Reshape Rare Disease Diagnosis using Pioneering MendelScan Technology Ipsen
09-Feb-2021 Scottish Medicines Consortium accepts PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer Takeda
09-Feb-2021 ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV ViiV Healthcare
09-Feb-2021 Nass Valley Gateway Ltd. Announces It Will Add CBD Veteran Jeanine Getz to Its Board of Directors Nass Valley Gateway Ltd.
09-Feb-2021 UCL becomes first global academic institution to offer comprehensive Masters of Surgery (MS) in Aesthetics and Minimally-Invasive Aesthetics UCL